Quinacrine hydrochloride added to 503B bulks list
FDA has added quinacrine hydrochloride to its list of bulk drug substances that can be used in compounding by outsourcing facilities...
Missed our GFI 256 compliance webinar? Now watch it on-demand
Find out what you need to know about GFI 256 by purchasing access to the recent GFI 256 compliance webinar, sponsored by APC and PCCA. It’s now available on-demand until June 15 for $25 (no CE credit).
A short story of persistence and potential
APC members Stuart Johnson and his wife Brandi, of Aiken, SC, didn’t know their US Senator Tim Scott, but they signed up to meet with his staffer last September during Compounders on Capitol Hill.
Harshbarger, Carter question CVM leader
Yesterday, the House Energy and Commerce Committee's Health Subcommittee held a hearing on reauthorizing the animal drug user fee...
Owner Summit is done: See you in 2024!
Earlier this week, APC hosted its third annual Owner Summit in Point Clear, Alabama.
Racehorses, compounding and confusion
In recent weeks there’s been a persistent rumor that the governing body for horse-racing has banned compounded drugs because they are not FDA approved. But that’s not the case.
Coming soon: Compounding certificate program for your new hires
Later this spring, we’ll be debuting a new 15-hour certificate program, “The Ethical, Legal, and Regulatory Framework of Pharmacy Compounding.”
California BOP compounding proposals out of sync with national standards
The California Board of Pharmacy’s Enforcement and Compounding Committee met yesterday to discuss proposed regulations related to sterile compounding.